Changes in co-therapies after initiation of disease-modifying anti-rheumatic drugs (DMARDs) therapy in patients with rheumatoid arthritis

OBJECTIVES: We hypothesized that initiation of a new disease modifying anti-rheumatic drug DMARD) for rheumatoid arthritis (RA) treatment would decrease use of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotics. METHODS: Using administrative databases we assembled 4 retrosp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kawai, Vivian K., Grijalva, Carlos G., Arbogast, Patrick G., Curtis, Jeffrey R., Solomon, Daniel H., Delzell, Elizabeth, Chen, Lang, Ouellet-Hellstrom, Rita, Herrinton, Lisa, Liu, Liyan, Mitchell, Edward F., Stein, C. Michael, Griffin, Marie R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227007/
https://ncbi.nlm.nih.gov/pubmed/22121511
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares